Skip to main content
Zydus Wellness Limited logo

Zydus Wellness Limited — Investor Relations & Filings

Ticker · ZYDUSWELL ISIN · INE768C01028 LEI · 335800YCS4FG8P1D1Y21 BSE.NS Manufacturing
Filings indexed 900 across all filing types
Latest filing 2025-06-26 Regulatory Filings
Country IN India
Listing BSE.NS ZYDUSWELL

About Zydus Wellness Limited

https://www.zyduswellness.com/

Zydus Wellness Limited is a consumer wellness organization dedicated to providing products that support a healthy lifestyle. The company manages a portfolio of established brands across several categories, including nutritional supplements, energy drinks, sweeteners, skincare, and healthy spreads. Its core product lineup features Sugar Free, a leading brand in the sugar substitute market; Glucon-D, a prominent glucose-based energy drink; and Complan, a fortified health food drink. Additionally, the portfolio includes Nycil prickly heat powder, Everyuth skincare products, and Nutralite table spreads. The company focuses on product innovation and quality to meet the demands of health-conscious consumers. Through a combination of research-driven development and a comprehensive distribution infrastructure, the entity provides functional wellness solutions designed to enhance the daily lives of its target audience.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing about the closure of the trading window for insiders due to upcoming unaudited quarterly financial results. It references the quarter ending June 30, 2025, and mentions the date of the board meeting for approval of these results will be informed later. The document does not contain any financial data or results itself, nor does it include a report or detailed financial statements. It is an announcement related to compliance with insider trading regulations ahead of a financial disclosure. Given the short length (1337 characters) and the nature of the content, this is not a financial report but a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2025-06-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) regarding the in-principle approval for voluntary liquidation of a wholly owned subsidiary of the company. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provides detailed disclosures as required under Regulation 30 of the Listing Regulations. The content focuses on corporate restructuring, liquidation approval, and related regulatory disclosures rather than financial results, management discussion, or audit information. The document is relatively short (4915 characters) and serves as a regulatory disclosure about a corporate event rather than a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2025-06-24 English
Copy of Newspaper Publication
Regulatory Filings
2025-06-21 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the company's ESG (Environmental, Social, and Governance) score assigned by an external rating provider for the financial year 2023-24. It references compliance with SEBI regulations and circulars related to listing obligations. The content is an announcement of an ESG rating score, not a detailed ESG report or annual report. The document length is only 1567 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Environmental & Social Information (SR) as it relates to ESG performance disclosure, but since it is only an intimation of the ESG score and not a full ESG report, and given the short length, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory disclosure under SEBI rules without substantive ESG report content.
2025-06-19 English
Updates
Director's Dealing Classification · 100% confidence The document is a disclosure under insider trading regulations, specifically referencing Form "B" under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. It details the disposal of shares by a close relative of a company executive. The content is a formal regulatory disclosure about insider trading and share transactions by a director or related person. It does not contain financial statements, earnings data, or management commentary. It is a report of personal share transactions by company directors/executives or their relatives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains detailed transaction data, confirming it is not a mere announcement or certification but a full disclosure filing.
2025-06-11 English
Updates
Director's Dealing Classification · 100% confidence The document is a disclosure under insider trading regulations, specifically Form B under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details the acquisition of shares by a company secretary and is addressed to stock exchanges. The content is a regulatory compliance filing about insider share transactions, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a formal regulatory disclosure. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length and detail support this classification with high confidence.
2025-06-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.